Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1352793.RARIaB-_NseSP7P_KjWO3NVYqUR6wu5CJbTHbbQPNB1wk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1352793.RARIaB-_NseSP7P_KjWO3NVYqUR6wu5CJbTHbbQPNB1wk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1352793.RARIaB-_NseSP7P_KjWO3NVYqUR6wu5CJbTHbbQPNB1wk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1352793.RARIaB-_NseSP7P_KjWO3NVYqUR6wu5CJbTHbbQPNB1wk130_provenance.
- NP1352793.RARIaB-_NseSP7P_KjWO3NVYqUR6wu5CJbTHbbQPNB1wk130_assertion description "[The levels of FGF-1 mRNA and FGF-2 and its mRNA tended to increase with dedifferentiation (especially grade G3), myometrial invasion (especially grade C) and staging (especially stages III and IV) in endometrial cancers were significantly (p < 0.05) higher than those in normal endometria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1352793.RARIaB-_NseSP7P_KjWO3NVYqUR6wu5CJbTHbbQPNB1wk130_provenance.
- NP1352793.RARIaB-_NseSP7P_KjWO3NVYqUR6wu5CJbTHbbQPNB1wk130_assertion evidence source_evidence_literature NP1352793.RARIaB-_NseSP7P_KjWO3NVYqUR6wu5CJbTHbbQPNB1wk130_provenance.
- NP1352793.RARIaB-_NseSP7P_KjWO3NVYqUR6wu5CJbTHbbQPNB1wk130_assertion SIO_000772 8685603 NP1352793.RARIaB-_NseSP7P_KjWO3NVYqUR6wu5CJbTHbbQPNB1wk130_provenance.
- NP1352793.RARIaB-_NseSP7P_KjWO3NVYqUR6wu5CJbTHbbQPNB1wk130_assertion wasDerivedFrom befree-2016 NP1352793.RARIaB-_NseSP7P_KjWO3NVYqUR6wu5CJbTHbbQPNB1wk130_provenance.
- NP1352793.RARIaB-_NseSP7P_KjWO3NVYqUR6wu5CJbTHbbQPNB1wk130_assertion wasGeneratedBy ECO_0000203 NP1352793.RARIaB-_NseSP7P_KjWO3NVYqUR6wu5CJbTHbbQPNB1wk130_provenance.
- befree-2016 importedOn "2016-02-19" NP1352793.RARIaB-_NseSP7P_KjWO3NVYqUR6wu5CJbTHbbQPNB1wk130_provenance.